Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.6750 (7.92%) ($9.6750 - $9.6750) on Sun. Jan. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.89% (three month average) | RSI | 55 | Latest Price | $9.6750(7.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 3.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -2.445% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.445% (StdDev 4.89%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.94(8.22%) | 10 Day Moving Average | $8.57(12.89%) | 20 Day Moving Average | $8.63(12.11%) | To recent high | -26.9% | To recent low | 23.9% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |